Can a home BP monitor and a support team close the hypertension gap for black patients?

NCT ID NCT06527794

First seen Jun 02, 2026

Summary

This study enrolls 864 Black adults with uncontrolled high blood pressure to see if a home monitoring program with pharmacist and community health worker support works better than usual clinic care. Participants will either get a home BP monitor plus remote medication management and social support, or standard care with a home monitor. The main goal is to see how many achieve blood pressure below 130 mmHg after 12 months.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UNCONTROLLED HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Wake Forest University Health Sciences

    RECRUITING

    Winston-Salem, North Carolina, 27157, United States

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Home blood pressure telemonitoring with pharmacist-led medication management and community health worker support

What this could lead to

If successful, this approach could offer a practical, scalable way to improve blood pressure control and reduce health disparities in Black patients with hypertension.

What could go wrong

This is a behavioral intervention trial, not a drug study, so results depend on patient engagement and adherence. The effect may vary across different communities and healthcare settings.

Conditions

The condition(s) this trial relates to.

hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.